Fikrig E, Barthold S W, Persing D H, Sun X, Kantor F S, Flavell R A
Section of Immunobiology, Yale University School of Medicine, New Haven, CT 06510.
J Immunol. 1992 Apr 1;148(7):2256-60.
Mice vaccinated with outer surface protein A (OspA) from Borrelia burgdorferi strain N40 are protected from challenge with an intradermal syringe inoculum of B. burgdorferi strains N40, B31, and CD16. Vaccination experiments were done to determine if protection extended to strains 297 and 25015. We now show that OspA-N40 immunized mice are protected against challenge with strain 297, isolated from the cerebrospinal fluid of a patient with neuroborreliosis, but not against challenge with strain 25015, isolated from a tick in Millbrook, NY. The OspA gene from strain 25015 was therefore cloned and sequenced. The deduced OspA-25015 protein sequence differs from OspA-N40 at 40 of 273 amino acids. Furthermore, mice vaccinated with rOspA-25015 are protected from challenge with strain 25015 but not against strain N40. The results extend the usefulness of OspA as a vaccine candidate, but indicate that OspA can vary among strains of B. burgdorferi and that vaccination of mice with OspA-N40 does not protect against intradermal challenge with an inoculum of 10(4) strain 25015 spirochetes.
用来自伯氏疏螺旋体菌株N40的外表面蛋白A(OspA)接种的小鼠,可免受用N40、B31和CD16伯氏疏螺旋体菌株皮内注射器接种物的攻击。进行了疫苗接种实验以确定这种保护作用是否扩展到297和25015菌株。我们现在表明,用OspA-N40免疫的小鼠可免受从神经莱姆病患者脑脊液中分离出的297菌株的攻击,但不能免受从纽约米尔布鲁克的一只蜱中分离出的25015菌株的攻击。因此,克隆并测序了25015菌株的OspA基因。推导的OspA-25015蛋白序列在273个氨基酸中的40个氨基酸处与OspA-N40不同。此外,用rOspA-25015接种的小鼠可免受25015菌株的攻击,但不能免受N40菌株的攻击。这些结果扩展了OspA作为候选疫苗的用途,但表明OspA在伯氏疏螺旋体菌株之间可能存在差异,并且用OspA-N40接种小鼠不能保护其免受10(4) 25015菌株螺旋体接种物的皮内攻击。